CRT 2026

Panel Discussion | Can We and Should We Skip TEE for LAA Closure? Role of CT and ICE?

Moderator(s)

• 

  Creighton W. Don, MD

  Professor of Medicine/Cardiology Director of the Interventional Cardiology and Structural Heart Fellowships
  University of Washington
  Seattle, Washington, United States

  Disclosure(s): No financial relationships to disclose
• 

  Antonio Frangieh, MD

  Medical Director Structural Heart Program, Associate Professor of Medicine
  University Of California Irvine
  Orange, California, United States

  Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Jacqueline Saw, MD

  Clinical Professor
  University of British Columbia, British Columbia, Canada

  Disclosure information not submitted.

Panel Discussant(s)

• 

  Karim Al-Azizi, MD, FACC, FSCAI, FESC

  Medical Director, Cardiac Catheterization Laboratories
  The Heart Hospital, Baylor Scott & White Health Baylor Scott & White
  Frisco, Texas, United States

  Disclosure information not submitted.
• 

  Haim Danenberg, MD

  Head of interventional cardiology
  Wolfson Medical Center
  Holon, Israel

  Disclosure information not submitted.
• 

  Chetan Huded, MD, MSc

  Associate Medical Director, Structural Intervention
  Saint Luke's Mid America Heart Institute
  Kansas City, Missouri, United States

  Disclosure(s): Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Proctor (Ongoing)
• 

  Tai Pham, MD

  Assistant Clinical Professor
  University of California, Davis
  Sacramento, California, United States

  Disclosure information not submitted.